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Abstract
A genetic analysis of age of onset of alcoholism was performed on the Collaborative Study on the
Genetics of Alcoholism data released for Genetic Analysis Workshop 14. Our study illustrates an
application of the log-normal age of onset model in our software Genetic Epidemiology Models
(GEMs). The phenotype ALDX1 of alcoholism was studied. The analysis strategy was to first find
the markers of the Affymetrix SNP dataset with significant association with age of onset, and then
to perform linkage analysis on them. ALDX1 revealed strong evidence of linkage for marker
tsc0041591 on chromosome 2 and suggestive linkage for marker tsc0894042 on chromosome 3.
The largest separation in mean ages of onset of ALDX1 was 19.76 and 24.41 between male
smokers who are carriers of the risk allele of tsc0041591 and the non-carriers, respectively. Hence,
male smokers who are carriers of marker tsc0041591 on chromosome 2 have an average onset of
ALDX1 almost 5 years earlier than non-carriers.
Background
Past Collaborative Study on the Genetics of Alcoholism
(COGA) results suggest that genetic linkage of alcohol
dependence to markers on chromosomes 1, 2, 4, and 7
deserves further studies [1-3]. For Genetic Analysis Work-
shop 14 (GAW14), an expanded dataset with far denser
marker sets has been provided. Our intent is to illustrate
some of the models implemented in our software Genetic
Epidemiology Models (GEMs) [4], in particular the regres-
sive models for combined segregation and linkage analy-
sis [5]. Previous analyses of COGA data have used
regressive types of models as well. The analysis by Tiwari
et al. provided strong association for chromosome 2 but
no strong evidence of linkage [2], while the version by
George et al. provided strong association for chromo-
somes 2 and 7 and nominal significance of linkage to
chromosomes 1 and 4 [3]. Here we concentrate on age of
onset of ALDX1 on a log-normal scale.
Methods
We focused on ALDX1 and its age of onset. We used the
given definition of alcoholism, ALDX1: classes 1, 2, 3, 4
were coded as unaffected and class 5 as affected. The data
had the following characteristics: 143 pedigrees; 1,614
persons; 643 affecteds; 735 unaffected; 356 male smokers;
297 male non-smokers; 245 female smokers; and 470
female non-smokers.
We adapted the well known Elston-Stewart [6] likelihood
framework for the analysis. The components of the likeli-
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hood model are the following: the population disease
gene and marker frequencies, transmission probabilities,
which for linkage analysis depend on the recombination
fraction, θ, and the probability model for the penetrance
function. The age-of-onset model of Elston [7] uses a mix-
ture formulation for the penetrance function. Here, we
use the simpler log-normal density model more common
in survival analysis in which the unaffected are assumed
censored at the age at last examination. The mean of the
log-normal is a function of genotype and other explana-
tory variables, but the variance is constant across geno-
types. This version of the log-normal age-of-onset model
is implemented in our software GEMs, which makes it
easy to specify interaction terms, add residual covariation
as in the regressive models of Bonney [8,9], and Bonney
et al. [5], and ascertainment corrections as in Bonney [10],
as needed.
The mean age of onset on the log scale is a linear function
of the disease genotype (assuming single locus and coded
as a dummy variable), marker locus, sex, and smoking,
also coded as dummy variables. Products of these varia-
bles are included to study interactions. The versions of the
model applied to ALDX1 differed only in the specification
of the mean age of onset, µ. Using the subscript g  to
denote genotype at the unobserved disease locus coded by
the dummy variable Xg, and subscript m for the marker
locus, we applied one model for association and three dif-
ferent models for linkage analysis.
Association model
µ = β0 + βm•Xm
Disease to marker association is tested by comparing the
hypotheses βm = 0 and βm≠ 0 using the likelihood ratio
and its asymptotic chi-square with 1 degree of freedom.
The analysis strategy first used marker association tests as
a preliminary screening procedure to pick up markers for
linkage study. Markers found significant at the 0.0001
level were tested further for linkage.
Linkage model I
The mean age of onset depends on the interaction of
marker and disease genotype:
µ = β0 + βg•Xg•Xm.
Linkage model II
The mean age of onset depends on the interaction of
marker and disease genotype, and a linear sex effect:
µ = β0 + βg•Xg•Xm + βsex•Xsex.
Model III
The mean age of onset depends on the interaction of
marker and disease genotypes, sex, smoking, and the,
interaction of gender and smoking, thus
µ  =  β0  +  βg•Xg•Xm  +  βsex•Xsex  +  βsmoker•Xsmoker  +
βsex_smoking•Xsex•Xsmoking.
Note that the association model does not include the
unobserved disease genotype, but the linkage models do.
Note also that the linkage models include disease locus
and marker locus interaction but not their "main effects".
Doing so led to horrible convergence problems due to
"over fitting". For a test of linkage, LOD scores were calcu-
lated as usual from the formula
LOD score = Log10{max likelihood (0 ≤ θ ≤ 1/2)}/{max
likelihood (θ = 1/2)}.
The significance of the effects of covariates, sex and smok-
ing, were tested by usual comparison of the estimates of
the coefficients with their standard errors, making the jus-
tified assumption that the sample was large enough for
Table 1: Linkage LOD scores for age of onset of ALDX1.
Chrom Markers Distance (cM) LOD scores
Model I Model II Model III
1 tsc0056724 139.838 0.78 0.24 0.77
2 tsc0041591 200.911 3.25 3.39 3.75
tsc0512083 200.914 0.99 1.05 1.32
3 tsc0894042 120.770 1.94 1.94 2.01
5 tsc1640504 96.473 0.66 0.65 0.63
10 tsc0597718 120.955 0.86 0.86 0.84BMC Genetics 2005, 6:S119
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the likelihood estimates to have approximate normal dis-
tribution.
Results
Association and linkage results for observed marker geno-
types are presented in Table 1. The markers presented are
those that showed significant association with the age of
onset of ALDX1. The association results identified five
markers for ALDX1; these were then tested for linkage. For
Model II, sex as a covariate is significant at p-value of 0.05
level. Females have a lower mean age of onset than males.
The first (Model I) and second (Model II) linkage results
revealed significant LOD scores for marker tsc0041591 on
chromosome 2 and suggestive linkage for marker
tsc0894042 on chromosome 3.
For Model III, using chromosome 2 marker tsc0041591,
with the addition of smoking status and interaction of sex
and smoking, the estimated regression coefficient for the
interaction of sex and smoking was significant at the 0.05
level of significance. Male smokers have a lower mean age
of onset than females. The linkage tests showed higher
LOD scores for marker tsc0041591 on chromosome 2.
The LOD scores for chromosome 3 marker tsc0894042 are
similar for Models I, II, and III. However, sex, smoking
and their interaction are not significant at the 0.05 level.
Hence the effect of chromosome 3 marker tsc0894042 on
alcoholism appears to be purely genetic, while that of
chromosome 2 marker tsc0041591 is significant by itself
but is even more marked among smokers. Table 2 displays
the mean ages of onset of ALDX1 according to sex, smok-
ing history, and marker carrier status for allele 1, the risk
allele of tsc0041591 on chromosome 2. The mean age of
onset of all ALDX1 cases is 22.18 for males and 23.18 for
females. The mean age of onset of the risk allele carriers is
lower, 20.39 for males and 22.78 for females; and that of
non-carriers is higher, 23.63 for males and 24.41 for
females. The lowest mean age of onset of ALDX1 occurs in
smokers who are risk allele carriers; their onset of ALDX1
occurs almost 5 years younger on average.
Furthermore, Figure 1 shows that the difference in mean
age of onset between males and females is significant for
risk allele carriers but not significant for non-risk allele
carriers. In Figure 2, the difference in mean age-of-onset
for non-risk allele carriers for smokers and non-smokers is
not significant while the difference for risk allele carriers is
dramatically different.
Discussion
Some general patterns are evident for Models I, II, and III.
The markers that showed significant LOD scores without
smoking as a covariate revealed higher LOD scores with
smoking. The markers with non-significant LOD scores
without smoking status as a covariate were also non-sig-
nificant when smoking was added to the covariates.
We reduced the number of markers and chromosomes by
performing association tests and then determining the
evidence of linkage on the selected markers. However, in
performing this reduction we are assuming no association
leads to no evidence of linkage.
We selected markers that showed association at 0.01 sig-
nificance level and tested them for linkage. There were
many more markers significant at p-values of 0.05 for the
association test. It is possible that we have missed some
important markers in our conservative strategy of analysis.
Conclusion
In summary, the markers tsc0041591 and tsc0512083 on
chromosome 2 and tsc0894042  on chromosome 3
revealed strong or suggestive linkage for alcoholism. LOD
score values increased among smokers for markers
tsc0512083 and tsc0512083 on chromosome 2 but not for
marker tsc0894042 on chromosome 3. The effect of sex on
the genetics of alcoholism was not as strong as that of
smoking.
Concerning our tool, GEMs, we found the speed of com-
putation to be very slow for the genome scan data. The
version used did not utilize parallel processing. Moreover,
Table 2: Mean age of onset for ALDX1 and marker tsc0041591 allele 1.
Allele 1 carriers (SEM) All ALDX1 cases (SEM) Non-carrier cases (SEM)
Sex Male 20.39 (0.70)a 22.18 (0.40) 23.63 (0.65)
Female 22.78 (0.95) 23.51 (0.60) 24.41 (1.12)
Smoker Yes 19.76 (0.59)a 22.60 (0.43) 24.42 (0.75)
No 23.24 (1.04) 22.50 (0.53) 22.83 (0.84)
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the largest LOD scores sometimes only reflected local
optimum conditions. The solution is to use several differ-
ent initial estimates. This has now been automatically
implemented in GEMs.
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Age of onset by allele and sex Figure 1
Age of onset by allele and sex.
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Age of onset by allele and smoking status Figure 2
Age of onset by allele and smoking status.
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